Vista Pharma.

3
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE427C01021
  • NSEID:
  • BSEID: 524711
INR
8.00
-0.13 (-1.6%)
BSENSE

Dec 17

BSE+NSE Vol: 9.5 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -2.07% vs 924.99% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -21.53% vs 25.42% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -20.97% vs 0.52% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -3.03% vs 20.31% in Mar 2024

Compare Profit and Loss Results of Vista Pharma.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
10.00
854.00
-844.00
-98.83%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
10.00
854.00
-844.00
-98.83%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
10.00
-10.00
-100.00%
Raw Materials Consumed
7.00
830.00
-823.00
-99.16%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
2.00
0.00
2.00
0%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
14.00
844.00
-830.00
-98.34%
Operating Profit (PBDIT) excl Other Income
-4.00
10.00
-14.00
-140.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
-3.00
10.00
-13.00
-130.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
-4.00
10.00
-14.00
-140.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
-5.00
10.00
-15.00
-150.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-5.00
10.00
-15.00
-150.00%
Provision for Tax
0.00
2.00
-2.00
-100.00%
Profit After Tax
-4.00
7.00
-11.00
-157.14%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-10.00
4.00
-14.00
-350.00%
Profit Available for appropriations
-15.00
11.00
-26.00
-236.36%
Appropriations
-15.00
11.00
-26.00
-236.36%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.79
0.04
-0.83
-2,075.00%
Profit And Loss - Net Sales
Net Sales 10.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.07% vs 924.99% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -4.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -21.53% vs 25.42% in Mar 2024

Profit And Loss - Interest
Interest 0.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -20.97% vs 0.52% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -4.65 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -3.03% vs 20.31% in Mar 2024